These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11773089)

  • 1. Comparative analysis of two commercial phenotypic assays for drug susceptibility testing of human immunodeficiency virus type 1.
    Qari SH; Respess R; Weinstock H; Beltrami EM; Hertogs K; Larder BA; Petropoulos CJ; Hellmann N; Heneine W
    J Clin Microbiol; 2002 Jan; 40(1):31-5. PubMed ID: 11773089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antivirogram or phenosense: a comparison of their reproducibility and an analysis of their correlation.
    Wang K; Samudrala R; Mittler JE
    Antivir Ther; 2004 Oct; 9(5):703-12. PubMed ID: 15535407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the precision and sensitivity of the Antivirogram and PhenoSense HIV drug susceptibility assays.
    Zhang J; Rhee SY; Taylor J; Shafer RW
    J Acquir Immune Defic Syndr; 2005 Apr; 38(4):439-44. PubMed ID: 15764961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study).
    Zolopa AR; Lazzeroni LC; Rinehart A; Vezinet FB; Clavel F; Collier A; Conway B; Gulick RM; Holodniy M; Perno CF; Shafer RW; Richman DD; Wainberg MA; Kuritzkes DR
    Clin Infect Dis; 2005 Jul; 41(1):92-9. PubMed ID: 15937768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors.
    Saladini F; Giannini A; Boccuto A; Vicenti I; Zazzi M
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28303602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-naive patients experiencing viremia on stavudine-containing regimens.
    Ross L; Scarsella A; Raffanti S; Henry K; Becker S; Fisher R; Liao Q; Hirani A; Graham N; St Clair M; Hernandez J;
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1107-15. PubMed ID: 11522180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A direct comparison of drug susceptibility to HIV type 1 from antiretroviral experienced subjects as assessed by the antivirogram and PhenoSense assays and by seven resistance algorithms.
    Ross L; Boulmé R; Fisher R; Hernandez J; Florance A; Schmit JC; Williams V
    AIDS Res Hum Retroviruses; 2005 Nov; 21(11):933-9. PubMed ID: 16386109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing.
    Harrigan PR; Montaner JS; Wegner SA; Verbiest W; Miller V; Wood R; Larder BA
    AIDS; 2001 Sep; 15(13):1671-7. PubMed ID: 11546942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs.
    Dunne AL; Mitchell FM; Coberly SK; Hellmann NS; Hoy J; Mijch A; Petropoulos CJ; Mills J; Crowe SM
    AIDS; 2001 Aug; 15(12):1471-5. PubMed ID: 11504978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of an in-house genotypic antiretroviral resistance assay in patients pretreated with multiple human immunodeficiency virus type 1 protease and reverse transcriptase inhibitors.
    Peduzzi C; Pierotti P; Venturi G; Romano L; Mazzotta F; Zazzi M
    J Clin Virol; 2002 Jul; 25(1):57-62. PubMed ID: 12126722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic testing for human immunodeficiency virus type 1 drug resistance.
    Shafer RW
    Clin Microbiol Rev; 2002 Apr; 15(2):247-77. PubMed ID: 11932232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1.
    Garcia-Perez J; Sanchez-Palomino S; Perez-Olmeda M; Fernandez B; Alcami J
    J Med Virol; 2007 Feb; 79(2):127-37. PubMed ID: 17177310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
    Little SJ; Daar ES; D'Aquila RT; Keiser PH; Connick E; Whitcomb JM; Hellmann NS; Petropoulos CJ; Sutton L; Pitt JA; Rosenberg ES; Koup RA; Walker BD; Richman DD
    JAMA; 1999 Sep 22-29; 282(12):1142-9. PubMed ID: 10501117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay.
    Choi JY; Kwon OK; Choi SY; Park YK; Kim SS
    J Clin Virol; 2011 Jan; 50(1):19-25. PubMed ID: 20970373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and performance of conventional HIV-1 phenotyping (Antivirogram®) and genotype-based calculated phenotyping assay (virco®TYPE HIV-1) on protease and reverse transcriptase genes to evaluate drug resistance.
    Pattery T; Verlinden Y; De Wolf H; Nauwelaers D; Van Baelen K; Van Houtte M; Mc Kenna P; Villacian J
    Intervirology; 2012; 55(2):138-46. PubMed ID: 22286884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates.
    Whitcomb JM; Huang W; Limoli K; Paxinos E; Wrin T; Skowron G; Deeks SG; Bates M; Hellmann NS; Petropoulos CJ
    AIDS; 2002 Oct; 16(15):F41-7. PubMed ID: 12370521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel.
    Wegner SA; Brodine SK; Mascola JR; Tasker SA; Shaffer RA; Starkey MJ; Barile A; Martin GJ; Aronson N; Emmons WW; Stephan K; Bloor S; Vingerhoets J; Hertogs K; Larder B
    AIDS; 2000 May; 14(8):1009-15. PubMed ID: 10853983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid screening of phenotypic resistance to nevirapine by direct analysis of HIV type 1 reverse transcriptase activity in plasma.
    Vázquez-Rosales G; García Lerma JG; Yamamoto S; Switzer WM; Havlir D; Folks TM; Richman DD; Heneine W
    AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1191-200. PubMed ID: 10480632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of three human immunodeficiency virus genotyping systems: the HIV-GenotypR method, the HIV PRT GeneChip assay, and the HIV-1 RT line probe assay.
    Wilson JW; Bean P; Robins T; Graziano F; Persing DH
    J Clin Microbiol; 2000 Aug; 38(8):3022-8. PubMed ID: 10921971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 drug resistance in newly infected individuals.
    Boden D; Hurley A; Zhang L; Cao Y; Guo Y; Jones E; Tsay J; Ip J; Farthing C; Limoli K; Parkin N; Markowitz M
    JAMA; 1999 Sep 22-29; 282(12):1135-41. PubMed ID: 10501116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.